Browsing Tag
Jagsonpal Pharmaceuticals Limited
5 posts
Why paediatric therapies could be Jagsonpal Pharmaceuticals’ next big growth driver in FY26
Jagsonpal Pharmaceuticals is scaling paediatric therapies, aiming to capture gut health, cough, and anti-diarrhoeal demand as child healthcare awareness rises in India.
Can Jagsonpal Pharmaceuticals’ dermatology push turn into a breakout growth segment?
Jagsonpal Pharmaceuticals is expanding its dermatology portfolio, aiming to turn anti-fungal and skin-care therapies into its next big growth driver in India.
Is Jagsonpal Pharmaceuticals’ asset-light model a blueprint for mid-cap pharma growth in India?
Jagsonpal Pharmaceuticals’ asset-light model, zero-debt balance sheet, and 23% ROE show how mid-cap Indian pharma firms can grow without heavy capex.
Can Jagsonpal Pharmaceuticals’ gynae leadership give it an edge as women’s health awareness surges in India?
Jagsonpal Pharmaceuticals’ 90% gynaecologist reach and #7 CVM rank boost its edge as demand for hormone therapies and progesterone products grows in India.
Jagsonpal Pharmaceuticals Q1 FY26 results: Can sustained brand momentum and strong cash flows drive further growth in India’s domestic market?
Jagsonpal Pharmaceuticals’ Q1 FY26 revenue rose 23% YoY to ₹756M, with PAT doubling to ₹108M. Can strong cash flows fuel future inorganic growth?